CWIAX
Price
$71.54
Change
+$0.12 (+0.17%)
Updated
Dec 24 closing price
Net Assets
142.32B
LGCFX
Price
$20.35
Change
+$0.01 (+0.05%)
Updated
Dec 24 closing price
Net Assets
364.27M
Interact to see
Advertisement

CWIAX vs LGCFX

Header iconCWIAX vs LGCFX Comparison
Open Charts CWIAX vs LGCFXBanner chart's image
American Funds Capital World Gr&Inc 529A
Price$71.54
Change+$0.12 (+0.17%)
VolumeN/A
Net Assets142.32B
Lord Abbett Global Equity F
Price$20.35
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets364.27M
CWIAX vs LGCFX Comparison Chart in %
View a ticker or compare two or three
VS
CWIAX vs. LGCFX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWIAX is a Hold and LGCFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIAX has more cash in the bank: 142B vs. LGCFX (364M). CWIAX pays higher dividends than LGCFX: CWIAX (1.35) vs LGCFX (0.45). CWIAX was incepted earlier than LGCFX: CWIAX (24 years) vs LGCFX (9 years). LGCFX (1.57) is less costly to investors than CWIAX (0.78). LGCFX is a more actively managed with annual turnover of: 41.00 vs. CWIAX (27.00). LGCFX has a lower initial minimum investment than CWIAX: LGCFX (0) vs CWIAX (250). LGCFX annual gain was more profitable for investors over the last year : 19.57 vs. CWIAX (12.26). LGCFX return over 5 years is better than : 47.31 vs. CWIAX (33.62).
CWIAXLGCFXCWIAX / LGCFX
Total Expense Ratio0.780.75104%
Annual Report Gross Expense Ratio0.781.5750%
Fund Existence24 years9 years-
Gain YTD14.30222.07665%
Front Load4%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets142B364M39,011%
Annual Yield % from dividends1.350.45297%
Returns for 1 year12.2619.5763%
Returns for 3 years45.9777.2759%
Returns for 5 years33.6247.3171%
Returns for 10 years95.47N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBOX63.190.30
+0.48%
Rydex Biotechnology A
GSGSX47.620.22
+0.46%
Goldman Sachs Equity Income Svc
KLCKX10.620.02
+0.19%
Federated Hermes Kaufmann Large Cap R
BFGBX43.270.07
+0.16%
BlackRock Capital Appreciation K
FKINX2.50N/A
N/A
Franklin Income A1